Concentrations of zidovudine- and lamivudine-triphosphate according to cell type in HIV-seronegative adults

Peter L. Anderson, Jia Hua Zheng, Tracy King, Lane R. Bushman, Julie Predhomme, Amie Meditz, John Gerber, Courtney V. Fletcher

Research output: Contribution to journalArticle

25 Scopus citations

Abstract

INTRODUCTION: Concentrations of zidovudine (ZDV)- and lamivudine (3TC)-triphosphates (TP) have been quantified in unfractionated peripheral blood mononuclear cells (PBMC) from HIV+ patients. The objective of this study was to determine whether concentrations of ZDV-TP and 3TC-TP in PBMC reflect the concentrations within CD4 T cells in HIV-seronegative adults. METHODS: Volunteers had taken 300 mg of ZDV plus 150 mg of 3TC twice daily for ≥ 7 days. Blood (60 mL) was collected 2 or 5 h post observed dose. PBMC were processed into three cell fractions using CD4 magnetic immunobeads: CD4-purified cells; unfractionated PBMC; and CD4-depleted PBMC. TP were determined in each cell fraction with liquid chromatography-mass spectrometry and compared across cell types by non-parametric analyses. RESULTS: Six males and two females participated. The median (range) percentage of CD4 T cells (CD4%) in each fraction were: CD4-purified, 99%; unfractionated, 63% (range, 53-70); and CD4-depleted, 14% (range, 4-29). Corresponding median (range) ZDV-TP concentrations were 8.0 (5.3-10.3), 26.5 (12.9-42.2), and 34.2 (16.4-52.2) fmol/1 × 10 cells (Friedman P = 0.0008). The 3TC-TP values were 4.6 (2.3-6.7), 4.8 (3.5-8.8), and 6.8 (4.0-13.1) pmol//1 × 10 cells (Friedman P = 0.01). In mixed model analyses: ZDV-TP (fmol/1 × 10 cells) = 42-0.32 (CD4%); P < 0.001 and 3TC-TP (pmol/1 × 10 cells) = 7.3-0.03(CD4%); P = 0.003. CONCLUSIONS: In HIV-seronegative volunteers, 3TC-TP concentrations in PBMC reflected the concentrations within CD4 T cells, but ZDV-TP concentrations were more than 70% lower in CD4 T cells than in PBMC. Thus, TP concentrations differ according to cell type in vivo with corresponding efficacy and toxicity implications for cells with low or high triphosphates.

Original languageEnglish (US)
Pages (from-to)1849-1854
Number of pages6
JournalAIDS
Volume21
Issue number14
DOIs
StatePublished - Sep 2007

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Concentrations of zidovudine- and lamivudine-triphosphate according to cell type in HIV-seronegative adults'. Together they form a unique fingerprint.

  • Cite this

    Anderson, P. L., Zheng, J. H., King, T., Bushman, L. R., Predhomme, J., Meditz, A., Gerber, J., & Fletcher, C. V. (2007). Concentrations of zidovudine- and lamivudine-triphosphate according to cell type in HIV-seronegative adults. AIDS, 21(14), 1849-1854. https://doi.org/10.1097/QAD.0b013e3282741feb